Convergent coexpression of autism-associated genes suggests some novel risk genes may not be detectable in large-scale genetic studies
Calwing Liao, Mariana Moysés‐Oliveira, Celine E.F. De Esch, Riya Bhavsar, Xander Nuttle, Aiqun Li, Alex W. Yu, Nicholas D. Burt, Serkan Erdin, Jack Fu, Minghui Wang, Theodore Morley, Lide Han, Patrick A. Dion, Guy A. Rouleau, Bin Zhang, Kristen Brennand, Michael E. Talkowski, Douglas M. Ruderfer
Abstract
Autism spectrum disorder (ASD) is a heritable neurodevelopmental disorder characterized by deficits in social interactions and communication. Protein-altering variants in many genes have been shown to contribute to ASD; however, understanding the convergence across many genes remains a challenge. We demonstrate that coexpression patterns from 993 human postmortem brains are significantly correlated with the transcriptional consequences of CRISPR perturbations in human neurons. Across 71 ASD risk genes, there was significant tissue-specific convergence implicating synaptic pathways. Tissue-specific convergence was further demonstrated across schizophrenia and atrial fibrillation risk genes. The degree of ASD convergence was significantly correlated with ASD association from rare variation and differential expression in ASD brains. Positively convergent genes showed intolerance to functional mutations and had shorter coding lengths than known risk genes even after removing association with ASD. These results indicate that convergent coexpression can identify potentially novel genes that are unlikely to be discovered by sequencing studies.